ARCHIVES

NCI Suggests 75 Topics for SBIR Proposals

This article is from The Cancer Letter archive.

Vol. 11 No. 38 | October 4, 1985

Download PDF Visit The Full Archive

Related Articles

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

House panel investigating NIH handling of tissue specimens.

June 24, 2005

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

Howard Hughes Medical Institute Seeks up to 25 New Researchers

January 17, 2014

President’s Cancer Panel Road Show Producers Ideas For Improving Finding Mechanisms; NCI Buys Some

July 23, 1982

Cancer Meetings Listed

March 26, 1993